Solta Medical (a Bausch Health company)

Solta Medical, a Bausch Health Companies subsidiary headquartered in Bothell, Washington, is the creator of the iconic Thermage RF skin tightening brand. With over 5 million Thermage procedures performed globally and the complementary Clear + Brilliant and Fraxel laser platforms, Solta represents a significant franchise within Bausch Health's aesthetics segment (~$521M Q4 2025 segment revenue).

1. Financial & Market Performance

Solta Medical operates within Bausch Health's aesthetics segment, which generated approximately $521 million in Q4 2025 revenue. Thermage maintains its position as the gold standard in non-invasive skin tightening, with particular strength in Asian markets where it commands premium pricing and near-iconic brand recognition. The Thermage FLX platform, featuring enhanced cooling technology, has improved patient comfort and treatment adherence. Clear + Brilliant and Fraxel complement Thermage by addressing surface-level skin concerns. The company's diversified device portfolio provides resilience against category-specific demand fluctuations.

2. Manufacturing & Supply Chain

Solta Medical's primary manufacturing and R&D facility is located in Bothell, Washington, USA. The facility produces the complete Thermage, Clear + Brilliant, and Fraxel product lines under FDA Quality System Regulation (QSR) and ISO 13485 certification. The company maintains a global distribution network spanning 60+ countries, with particularly strong commercial infrastructure in the United States, China, South Korea, and Japan. Bausch Health's corporate infrastructure provides shared supply chain, regulatory, and quality assurance resources.

3. Key Developments & Strategic Outlook

Solta Medical is developing next-generation Thermage platforms with personalized energy delivery and AI-guided treatment protocols. The company is exploring applications of RF technology in women's health — a rapidly growing adjacent market. Strategic priorities include expanding the Clear + Brilliant franchise into hybrid clinic-home segments and deepening integration with Bausch Health's broader dermatology portfolio. Thermage's unrivaled consumer awareness in Asian markets, particularly China and South Korea, represents an enduring competitive advantage that is extremely difficult for competitors to replicate.